Tag Archives: FDA
FDA Approves Lilly’s Retevmo® (Selpercatinib) for RET Fusion–Positive Locally Advanced or Metastatic Solid Tumors
On September 21, 2022, the FDA has granted regular approval to selpercatinib (Retevmo®) 40 mg and 80 mg capsules for […]
ikrisuser
September 30, 2022
Cipla Gets the Final Approval for Generic Version of Revlimid by US FDA
On September 7’th, 2022, Cipla Ltd announced that it has received final approval for its generic version (ANDA) of Lenalidomide […]
ikrisuser
September 12, 2022
FDA Approves Xenpozyme: The First Disease-specific Medication for Acid Sphingomyelinase Deficiency (ASMD)
On August 31, 2022, the U.S. FDA approved Xenpozyme (Olipudase alfa) for intravenous infusion in pediatric and adult patients with […]
ikrisuser
September 8, 2022
FDA-approved Zynteglo: Cell-based gene therapy for beta-thalassemia
The FDA approved the first cell-based therapy on 17 August 22 for the treatment of adult and pediatric patients with […]
